Dual‐Loaded Nanoparticles Targeting Tumor Cell‐Intrinsic FABP5 Combined with RFA Synergistically Inhibit HCC Progression and Distant Metastasis. This evidence concerns the gene FABP5 and hepatocellular carcinoma.